Back to Journals » Drug Design, Development and Therapy

Drug Design, Development and Therapy

ISSN: 1177-8881


Editor-in-Chief: Prof. Dr. Frank Boeckler

An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal. 

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Latest articles:

- 5 records -

Sinomenine Hydrochloride Protects IgA Nephropathy Through Regulating Cell Growth and Apoptosis of T and B Lymphocytes

Li JJ, Li L, Li S, Tang XY, Sun HF, Liu JX

Drug Design, Development and Therapy 2024, 18:1247-1262

Published Date: 17 April 2024

Dexamethasone versus Dexmedetomidine as Adjuvants in Ultrasound Popliteal Sciatic Nerve Block for Hallux Valgus Surgery: A Mono-Centric Retrospective Comparative Study

Coviello A, Iacovazzo C, Cirillo D, Bernasconi A, Marra A, Squillacioti F, Martone M, Garone E, Coppola F, de Siena AU, Vargas M, Servillo G

Drug Design, Development and Therapy 2024, 18:1231-1245

Published Date: 17 April 2024

Clinical Application and Research Progress of Remimazolam for Pediatric Patients

Bai C, Xu M, Guo Y, Jin Y, Zhao X

Drug Design, Development and Therapy 2024, 18:1221-1229

Published Date: 17 April 2024


Read more articles